Opko Health (OPK) Depreciation & Amortization (CF) (2010 - 2026)

Opko Health (OPK) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $22.4 million in Q2 2026.

• Quarterly Depreciation & Amortization (CF) fell 2.68% year-over-year to $22.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $89.7 million (down 25.64% YoY) and the FY2025 annual result came in at $91.6 million, down 6.67% from the prior year.
• Depreciation & Amortization (CF) climbed to $22.4 million in Q2 2026, from $22.2 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $74.1 million in Q3 2024 to a low of $22.2 million in Q1 2026.
• A 5-year average of $29.5 million and a median of $26.2 million in 2023 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2024 — Depreciation & Amortization (CF) jumped 183.15% — and 2025, when it tumbled 69.33%.
• Tracing OPK's Depreciation & Amortization (CF) over 5 years: stood at $26.5 million in 2022, then slipped by 1.81% to $26.0 million in 2023, then jumped by 185.34% to $74.1 million in 2024, then tumbled by 69.82% to $22.4 million in 2025, then gained by 0.16% to $22.4 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $22.4 million (Q2 2026), $22.2 million (Q1 2026), and $22.4 million (Q4 2025), per Business Quant data.